ScholarIQanswers from OpenAlex

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

PaperCitations, authors & open-access status

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors have?

ScholarIQcitation count

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors has 1,247 citations in the OpenAlex counts ScholarIQ stores.

When was Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors published?

ScholarIQyear

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors has 2013 year in the ScholarIQ index.

What is the open-access status of Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors?

ScholarIQoa status

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors has hybrid oa status in the ScholarIQ index.

What is the DOI of Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors?

ScholarIQdoi

The DOI for Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors is on the source record.

What is the PMID of Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors?

ScholarIQpmid

The PMID for Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors is on the source record.

What is the OpenAlex record for Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors?

ScholarIQopenalex

The OpenAlex for Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial